FFM
RDY icon

Fullerton Fund Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Fullerton Fund Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-65,000
Closed -$666K – 25
2016
Q2 		$666K Buy
65,000
+5,000
+8% +$45.8K 0.43% 12
2016
Q1 		$542K Buy
60,000
+37,500
+167% +$335K 0.39% 13
2015
Q4 		$208K Sell
22,500
-1,055
-4% -$11.6K 0.16% 15
2015
Q3 		$301K Sell
23,555
-4,945
-17% -$61.4K 0.19% 10
2015
Q2 		$315K Buy
+28,500
New +$315K 0.18% 13

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fullerton Fund Management's RDY Position: Q3 2016 in Review

Fullerton Fund Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2016, closing a stake of 65,000 shares — an estimated $666K sold.

Fullerton Fund Management first reported a position in RDY in Q2 2015 and held it in 5 quarters. The position peaked at $666K in Q2 2016. 157 funds tracked by Wall St. Rank hold RDY as of Q3 2016.

  • Fullerton Fund Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2016 after selling out during the quarter.
  • Fullerton Fund Management sold 65,000 Dr. Reddy's Laboratories shares in Q3 2016, an estimated $666K.
  • Fullerton Fund Management first reported a position in Dr. Reddy's Laboratories in Q2 2015 and held it in 5 quarters.
  • Fullerton Fund Management's Dr. Reddy's Laboratories position peaked at $666K in Q2 2016.
  • 157 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2016.

Based on Fullerton Fund Management's 13F filing for Q3 2016, filed 14 Feb 2017.